Technology
Evolva develops novel genetic pathways leading to new drug candidates for the Healthcare industry. The patented Watchmaker® technology captures nature’s genetic chemistry pool and combines it with an evolutionary process leading to discovery and optimization of novel small molecules for therapeutic targets.
Value Proposition
The pharmaceutical industry has largely stopped exploring conventional natural products. Natural structures are typically difficult to source, difficult to identify, difficult to analog and difficult to manufacture. However, Nature is still the most efficient supplier of long lasting healthcare ingredients. Evolva´s Watchmaker® technology creates new combinations of synthetic structured products leading to new compounds that interact with the most productive functionalities of natural products. By mixing millions of genes from multiple species such as sponges, humans & plants, Watchmaker® creates long lasting solutions for patients with lifelong conditions.
Evolva is listed on the Swiss Stock Exchange as Evolva Holding SA.
Additional Information